(35 days)
No
The summary describes standard image and information system functionalities and enhancements, with no mention of AI or ML technologies.
No
The device is an image and information system intended to assist trained professionals in diagnosing and treating diseases by viewing and interpreting images and data, not directly providing therapy.
Yes
The device is intended to assist trained professionals in "diagnostic interpretation of images and other information for the diagnosis and treatment of cardiac and vascular disease." This directly indicates its role in the diagnostic process.
No
The device description explicitly lists hardware components such as "database server; application server; image and document storage server and media; long-term archive and disaster recovery media; and client application workstation."
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device function: The description of McKesson Cardiology™ focuses on the management, review, analysis, and reporting of digital cardiovascular images and information from other data sources. It's an image processing and information system.
- No mention of biological samples: There is no indication that this device processes or analyzes biological samples from patients. Its inputs are images and data, not bodily fluids or tissues.
Therefore, McKesson Cardiology™ falls under the category of medical imaging and information systems, not in vitro diagnostics.
N/A
Intended Use / Indications for Use
McKesson Cardiology™ is an integrated multimodality image and information system designed to perform the necessary functions required for import, export, storage, archival, review, analysis, quantification, reporting and database management of digital cardiovascular images and information from other data sources.
McKesson Cardiology™ is intended for use in the Cardiology, Radiology or other departments throughout the healthcare facility and distributed locations and may be part of a larger PACS configuration.
McKesson Cardiology™ offers support for third-party plug-ins in order to enable the use of commercially available tools for analysis, quantification and reporting.
McKesson Cardiology™ is intended to assist trained professionals in the viewing and diagnostic interpretation of images and other information for the diagnosis and treatment of cardiac and vascular disease.
Product codes (comma separated list FDA assigned to the subject device)
LLZ
Device Description
McKesson Cardiology™ is an image processing system. The device consists of the following components and accessories: software application; database server; application server; image and document storage server and media; long-term archive and disaster recovery media; and client application workstation.
The version of McKesson Cardiology, subject of this 510(k) includes enhancements and new features including those for supporting dictation and streamlining user workflow for documenting, charting and trending procedural related data for Cath and other reporting; Statistical data collection of non-invasive features use for adoption considerations; Security; DICOM display view; Storage and archival enhancements; Support for stress modalities XML data import; EP modalities data import and reporting; and, importing lab results and exporting procedure medications using standard HL7.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
multimodality image and information system
Anatomical Site
cardiac and vascular
Indicated Patient Age Range
Not Found
Intended User / Care Setting
trained professionals in the Cardiology, Radiology or other departments throughout the healthcare facility and distributed locations.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Verification and validation testing was performed on McKesson Cardiology to ensure it met all specifications. In addition, usability testing was performed, where applicable. The device was further validated to ensure that it performs as intended. Performance testing was conducted to verify compliance with specified design requirements in accordance with ISO 13485:2003, IEC 62304:2006 and ISO 14971:2007. Furthermore, DICOM conformance testing was performed to verify compliance with NEMA 3.1-3.20 (2011) standards. No clinical studies were necessary to support substantial equivalence. In all instances, McKesson Cardiology functioned as intended and the observed results demonstrate substantial equivalence with the predicate devices.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
McKesson Israel Ltd.'s Horizon Cardiology™ (K112720)
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
GE Medical Systems' Centricity Cardio Imaging (K112570)
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.2050 Medical image management and processing system.
(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo features a stylized caduceus symbol, which is a staff with two snakes coiled around it. The symbol is enclosed in a circle with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. The text is written in all capital letters.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
August 11, 2015
McKesson Israel Ltd. % Mr. Paul Sumner Director, Regulatory Affairs McKesson Technologies, Inc. 5995 Windward Parkway ALPHARETTA GA 30005
Re: K151850
Trade/Device Name: McKesson Cardiology" Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: II Product Code: LLZ Dated: July 7, 2015 Received: July 8, 2015
Dear Mr. Sumner:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
1
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours.
Michael O'Hara
For
Robert Ochs. Ph.D. Acting Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K151850
Device Name
McKesson CardiologyTM
Indications for Use (Describe)
McKesson Cardiology™ is an integrated multimodality image and information system designed to perform the necessary functions required for import, export, storage, archival, review, analysis, quantification, reporting and database management of digital cardiovascular images and information from other data sources.
McKesson Cardiology™ is intended for use in the Cardiology, Radiology or other departments throughout the healthcare facility and distributed locations and may be part of a larger PACS configuration.
McKesson Cardiology™ offers support for third-party plug-ins in order to enable the use of commercially available tools for analysis, quantification and reporting.
McKesson Cardiology™ is intended to assist trained professionals in the viewing and diagnostic interpretation of images and other information for the diagnosis and treatment of cardiac and vascular disease.
| Type of Use (Select one or both, as applicable) |
|---|
| Prescription Use (Part 21 CFR 801 Subpart D) |
| Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/1 description: The image shows the McKesson logo. The logo is in blue, except for a small orange rectangle under the 'C'. The text is bold and sans-serif.
510(k) SUMMARY
McKesson Israel Ltd. 26 HaRokmim St.Azriel Center, Building A Holon, 5885849, Israel
| Contact Person: | Gilbert Wong,
Vice President, Regulatory Operation
McKesson Medical Imaging Company
130 - 10711 Cambie Road
Richmond, BC
Canada V6X 3G5
Phone: 604-821-6338
Fax: 604-279-5468
E-mail: Gilbert.Wong@McKesson.com |
|----------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Date Prepared: | August 5, 2015 |
| Name of the device: | McKesson Cardiology™ |
| Common or Usual Name: | Imaging Processing System |
| Classification Name: | Picture archiving and communications system |
| Classification Regulation: | 21 C.F.R. § 892.2050 |
| Product code: | LLZ |
| Device Class: | Class II |
| Predicate Device: | McKesson Israel Ltd.'s Horizon Cardiology™ (K112720) |
| Reference Device: | GE Medical Systems' Centricity Cardio Imaging (K112570) |
Intended Use / Indications for Use
McKesson Cardiology™ is an integrated multimodality image and information system designed to perform the necessary functions required for import, export, storage, archival, review, analysis, quantification, reporting and database management of digital cardiovascular images and information from other data sources.
McKesson Cardiology™ is intended for use in the Cardiology, Radiology or other departments throughout the healthcare facility and distributed locations and may be part of a larger PACS configuration.
McKesson Cardiology™ offers support for third party plug-ins in order to enable the use of commercially available tools for analysis, quantification and reporting.
McKesson Cardiology™ is intended to assist trained professionals in the viewing and diagnostic interpretation of images and other information for the diagnosis and treatment of cardiac and vascular disease.
The version of McKesson Cardiology, subject of this 510(k), allows for the provision of additional information from expanded data sources to assist trained healthcare professionals
4
Image /page/4/Picture/1 description: The image shows the McKesson logo. The logo is in blue, except for a small orange rectangle under the 'C'. The text is bold and sans-serif.
throughout the healthcare facility and distributed locations in diagnosing and treating cardiac and vascular diseases.
The expansion of the indications for use to include other data sources and the usage of the device in distributed locations does not raise new questions of, or adversely affect the safety or effectiveness of the device. The intended use of McKesson Cardiology™ as a result of these changes remains the same as the predicate(s) and do not raise new questions as a result, or affect safety and effectiveness.
Technological Characteristics
McKesson Cardiology™ is an image processing system. The device consists of the following components and accessories: software application; database server; application server; image and document storage server and media; long-term archive and disaster recovery media; and client application workstation.
The version of McKesson Cardiology, subject of this 510(k) includes enhancements and new features including those for supporting dictation and streamlining user workflow for documenting, charting and trending procedural related data for Cath and other reporting; Statistical data collection of non-invasive features use for adoption considerations; Security; DICOM display view; Storage and archival enhancements; Support for stress modalities XML data import; EP modalities data import and reporting; and, importing lab results and exporting procedure medications using standard HL7.
Performance Data
Verification and validation testing was performed on McKesson Cardiology to ensure it met all specifications. In addition, usability testing was performed, where applicable. The device was further validated to ensure that it performs as intended. Performance testing was conducted to verify compliance with specified design requirements in accordance with ISO 13485:2003, IEC 62304:2006 and ISO 14971:2007. Furthermore, DICOM conformance testing was performed to verify compliance with NEMA 3.1-3.20 (2011) standards. No clinical studies were necessary to support substantial equivalence. In all instances, McKesson Cardiology functioned as intended and the observed results demonstrate substantial equivalence with the predicate devices.
Substantial Equivalence
McKesson Cardiology™ is substantially equivalent to McKesson Israel's Ltd.'s Horizon Cardiology™ (K112720), as well as GE Medical Systems' Centricity® Cardio Imaging (K112570). McKesson Cardiology™ has the same intended uses and similar indications, technological characteristics, and principles of operation as the predicate devices.
The minor technological differences between McKesson Cardiology™ and its predicate devices raise no new issues of safety or effectiveness. Thus, McKesson Cardiology™ is substantially equivalent to previously cleared predicate devices.